Mycenax Biotech

About:

Mycenax Biotech is a biologics CDMO company developing recombinant proteins, enzymes, antibodies, antibody-drug conjugates.

Website: https://www.mycenax.com.tw

Top Investors: JCR Pharmaceuticals

Description:

Mycenax Biotech provides biopharmaceutical services and solutions for drug development and production. Mycenax has moved its focus to developing technological platforms, creating and growing GMP operations, meeting a variety of customer needs, and offering simplified and customized CDMO services.

Total Funding Amount:

$56M

Headquarters Location:

Zhuan, Zhejiang, China

Founded Date:

2001-01-01

Contact Email:

Info(AT)mycenax.com.tw

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-07-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai